Cadonilimab Clinical Trials
28 recruitingDrug
Phase 224Phase 13Not Applicable2Phase 31
Showing 1–20 of 28 trials
Recruiting
Phase 1Phase 2
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
Akeso280 enrolled2 locationsNCT06530251
Recruiting
Phase 2
Ligufalimab and Cadonilimab in Advanced Liver Cancers
Biliary Tract CancerAdvanced Hepatocellular CarcinomaRefractory Hepatocellular Carcinoma
University of Texas Southwestern Medical Center64 enrolled1 locationNCT06789848
Recruiting
Phase 3
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Akeso760 enrolled6 locationsNCT07023315
Recruiting
Phase 1Phase 2
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd63 enrolled16 locationsNCT05944224
Recruiting
Phase 2
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
Cervical AdenocarcinomaGastric-type Endocervical Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology25 enrolled2 locationsNCT06654011
Recruiting
Phase 2
A Study of Ivonescimab in First-Line ES-SCLC
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso180 enrolled3 locationsNCT07245446
Recruiting
Phase 2
A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology53 enrolled1 locationNCT06367075
Recruiting
Phase 2
AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
Head and Neck Squamous Cell Carcinoma
Fudan University52 enrolled1 locationNCT06494995
Recruiting
Phase 2
Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology27 enrolled1 locationNCT06367088
Recruiting
Phase 1Phase 2
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer
Colorectal Cancer Stage IVMismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)
Sun Yat-sen University28 enrolled1 locationNCT05426005
Recruiting
Phase 2
Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Cervical Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University29 enrolled1 locationNCT06511726
Recruiting
Phase 2
Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC
Small Cell Lung Cancer
Sichuan University80 enrolled1 locationNCT06769971
Recruiting
Phase 2
AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC
Locally Advanced Pancreatic Ductal Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital30 enrolled1 locationNCT06472037
Recruiting
Phase 2
TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
Hepatocellular Carcinoma
Fei Gao30 enrolled1 locationNCT05882370
Recruiting
Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
Cervical Cancer
Fujian Cancer Hospital200 enrolled1 locationNCT06140589
Recruiting
Phase 2
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
Cervical CancerNeoadjuvant ChemoimmunotherapyRadical Hysterectomy+1 more
Tongji Hospital50 enrolled2 locationsNCT06289751
Recruiting
Not Applicable
Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
Metastatic Colorectal Cancer
Liu Huang80 enrolled1 locationNCT06551207
Recruiting
Phase 2
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Neoplasm MetastasisEndometrial NeoplasmsNeoplasm Recurrence, Local
Shandong Cancer Hospital and Institute30 enrolled1 locationNCT06532539
Recruiting
Phase 2
AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Harbin Medical University50 enrolled1 locationNCT06196697
Recruiting
Phase 2
Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC
NSCLC
Shanghai Pulmonary Hospital, Shanghai, China54 enrolled2 locationsNCT06424821